Company Number: 12599532

Analysis Date: 2025-07-20 15:59 UTC

1. Credit Opinion: DECLINE. The company is very new (incorporated in 2020) and has only filed micro-entity accounts. The financials show a negative net asset position (£-7,060) as of 31 May 2024, primarily due to liabilities exceeding assets. There is limited current asset coverage and significant liabilities falling due after more than one year (£36,000), creating a weak balance sheet. The absence of any turnover or profit data and the micro-entity filing category indicate very limited trading activity or scale. Without strong evidence of cash generation or equity support, the company’s ability to service debt or meet commercial obligations is questionable.

2. Financial Strength: The balance sheet shows fixed assets of £36,000 offset by long-term creditors of £36,000, resulting in zero net assets excluding current liabilities. Current liabilities of £3,480 exceed current assets of £200, resulting in negative net current assets of £3,280. Total net assets are negative at £-7,060. Share capital is nominal (£1). The negative equity and working capital deficit point to financial weakness and reliance on external funding or creditor support. This structure is typical of a company likely in early development or without mature trading.

3. Cash Flow Assessment: Current assets are minimal (£200), presumably cash or equivalents, while current liabilities (£3,480) are significantly higher, indicating potential short-term liquidity pressures. There is no indication of operating cash flow or turnover to support working capital needs. The company’s liquidity position is weak, with insufficient current assets to cover short-term obligations. This raises concerns about the company's ability to meet creditors as they fall due unless supported by owner funding or refinancing.

4. Monitoring Points:

• Monitor updated financial filings for evidence of revenue growth or improved profitability.
• Watch for changes in net current assets and net asset position to assess strengthening or further deterioration.
• Track director and shareholder funding activity for signs of capital injection or loan support.
• Review payment behavior and any defaults on trade or credit facilities.
• Observe compliance with filing deadlines and any changes in company status or director appointments.